Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

Progress in measurement instruments for acute and chronic gout studies.

Grainger R, Taylor WJ, Dalbeth N, Perez-Ruiz F, Singh JA, Waltrip RW, Schlesinger N, Evans R, Edwards NL, Sivera F, Diaz-Torne C, MacDonald PA, McQueen FM, Schumacher HR.

J Rheumatol. 2009 Oct;36(10):2346-55. doi: 10.3899/jrheum.090371.

PMID:
19820224
2.

Outcome evaluations in gout.

Schumacher HR, Taylor W, Joseph-Ridge N, Perez-Ruiz F, Chen LX, Schlesinger N, Khanna D, Furst DE, Becker MA, Dalbeth N, Edwards NL.

J Rheumatol. 2007 Jun;34(6):1381-5.

PMID:
17552064
3.

Establishing outcome domains for evaluating treatment of acute and chronic gout.

Grainger R, Taylor WJ.

Curr Opin Rheumatol. 2008 Mar;20(2):173-8. doi: 10.1097/BOR.0b013e3282f36cf1. Review.

PMID:
18349747
4.

Outcome measures in acute gout: a systematic literature review.

Dalbeth N, Zhong CS, Grainger R, Khanna D, Khanna PP, Singh JA, McQueen FM, Taylor WJ.

J Rheumatol. 2014 Mar;41(3):558-68. doi: 10.3899/jrheum.131244. Epub 2013 Dec 15. Review.

5.

Patient-reported outcomes in chronic gout: a report from OMERACT 10.

Singh JA, Taylor WJ, Simon LS, Khanna PP, Stamp LK, McQueen FM, Neogi T, Gaffo AL, Becker MA, MacDonald PA, Dabbous O, Strand V, Dalbeth ND, Aletaha D, Edwards NL, Schumacher HR Jr.

J Rheumatol. 2011 Jul;38(7):1452-7. doi: 10.3899/jrheum.110271.

6.

Outcome measures for acute and chronic gout.

Schumacher HR Jr, Edwards LN, Perez-Ruiz F, Becker M, Chen LX, Furst DE, Joseph-Ridge N, Schlesinger N, Horowitz Z, Saag K, Boice JA, Yamanaka H; OMERACT 7 Special Interest Group.

J Rheumatol. 2005 Dec;32(12):2452-5. Review.

PMID:
16331785
7.

Imaging as an Outcome Measure in Gout Studies: Report from the OMERACT Gout Working Group.

Grainger R, Dalbeth N, Keen H, Durcan L, Lawrence Edwards N, Perez-Ruiz F, Diaz-Torne C, Singh JA, Khanna D, Simon LS, Taylor WJ.

J Rheumatol. 2015 Dec;42(12):2460-4. doi: 10.3899/jrheum.141164. Epub 2015 Feb 1. Review.

8.

Fibromyalgia syndrome.

Mease P, Arnold LM, Bennett R, Boonen A, Buskila D, Carville S, Chappell A, Choy E, Clauw D, Dadabhoy D, Gendreau M, Goldenberg D, Littlejohn G, Martin S, Perera P, Russell IJ, Simon L, Spaeth M, Williams D, Crofford L.

J Rheumatol. 2007 Jun;34(6):1415-25.

PMID:
17552068
9.

Serum urate in chronic gout--will it be the first validated soluble biomarker in rheumatology?

Stamp LK, Khanna PP, Dalbeth N, Boers M, Maksymowych WP, Schumacher HR Jr, Becker MA, MacDonald PA, Edwards NL, Singh JA, Simon LS, McQueen FM, Neogi T, Gaffo AL, Strand V, Taylor WJ.

J Rheumatol. 2011 Jul;38(7):1462-6. doi: 10.3899/jrheum.110273.

10.

Serum urate as a soluble biomarker in chronic gout-evidence that serum urate fulfills the OMERACT validation criteria for soluble biomarkers.

Stamp LK, Zhu X, Dalbeth N, Jordan S, Edwards NL, Taylor W.

Semin Arthritis Rheum. 2011 Jun;40(6):483-500. doi: 10.1016/j.semarthrit.2010.09.003. Epub 2010 Nov 5. Review.

PMID:
21056459
11.
12.

Assessing quality of sleep in patients with rheumatoid arthritis.

Wells GA, Li T, Kirwan JR, Peterson J, Aletaha D, Boers M, Bresnihan B, Dougados M, Idzerda L, Nicklin J, Suarez-Almazor M, Welch V, Tugwell PS.

J Rheumatol. 2009 Sep;36(9):2077-86. doi: 10.3899/jrheum.090362. Review.

PMID:
19738217
13.

Overview of research on health-related quality of life in patients with chronic liver disease.

Gutteling JJ, de Man RA, Busschbach JJ, Darlington AS.

Neth J Med. 2007 Jul-Aug;65(7):227-34. Review.

14.

Systematic review of discriminating power of outcome measures used in clinical trials of fibromyalgia.

Carville SF, Choy EH.

J Rheumatol. 2008 Nov;35(11):2094-105. Epub 2008 Sep 15. Review.

PMID:
18792996
15.

Tophus measurement as an outcome measure for clinical trials of chronic gout: progress and research priorities.

Dalbeth N, McQueen FM, Singh JA, MacDonald PA, Edwards NL, Schumacher HR Jr, Simon LS, Stamp LK, Neogi T, Gaffo AL, Khanna PP, Becker MA, Taylor WJ.

J Rheumatol. 2011 Jul;38(7):1458-61. doi: 10.3899/jrheum.110272.

16.

Report from the OMERACT Hand Osteoarthritis Working Group: Set of Core Domains and Preliminary Set of Instruments for Use in Clinical Trials and Observational Studies.

Kloppenburg M, Bøyesen P, Visser AW, Haugen IK, Boers M, Boonen A, Conaghan PG, Hawker GA, Kvien TK, Landewé R, Uhlig T, Smeets W, Greibrokk E, van der Heijde DM.

J Rheumatol. 2015 Nov;42(11):2190-7. doi: 10.3899/jrheum.141017. Epub 2015 Jul 1. Review.

PMID:
26136489
17.

Consensus on a core set of domains for psoriatic arthritis.

Gladman DD, Mease PJ, Strand V, Healy P, Helliwell PS, Fitzgerald O, Gottlieb AB, Krueger GG, Nash P, Ritchlin CT, Taylor W, Adebajo A, Braun J, Cauli A, Carneiro S, Choy E, Dijkmans B, Espinoza L, van der Heijde D, Husni E, Lubrano E, McGonagle D, Qureshi A, Soriano ER, Zochling J.

J Rheumatol. 2007 May;34(5):1167-70.

PMID:
17477480
18.

Quality of life and quality of care for patients with gout.

Singh JA.

Curr Rheumatol Rep. 2009 Apr;11(2):154-60. Review.

19.

Assessment of outcome in psoriatic arthritis.

Taylor WJ.

Curr Opin Rheumatol. 2004 Jul;16(4):350-6. Review.

PMID:
15201596
20.

Updates in the management of gout.

Keith MP, Gilliland WR.

Am J Med. 2007 Mar;120(3):221-4. Review.

PMID:
17349440

Supplemental Content

Support Center